Dr. Aaron Ellenbogen D.O- Dr. Aaron Ellenbogen is a Board-Certified Neurologist with nearly 100 clinical trials completed. With 22+ years of research experience and 76 publications, he is now a KOL in his field, Movement Disorder Specialist, published physician, and active member of MDS. Through his years of experience, Dr. Ellenbogen has remained committed to the advancement of medicine for targeted diverse patient populations. Within his trial conduction portfolio, he has conducted trials among a plethora of therapeutic areas/trial indications. Among these, Alzheimer’s, Parkinson’s, MS, Pain Management, DPNP, and others.

Dr. Kiran Saraiya D.O
Dr. Kiran Saraiya is double Board-Certified in Internal Medicine and Nephrology, has been practicing since 2005, and since, remained pursuant after her passion within academia. Dr. Saraiya joined Quest Research Institute in 2019, an independent clinical research site with a 24-year track record. Her site specializes in Phase 1 research and has recently doubled in space to accommodate all phases with large volume recruitment. Trained nurses average 23+ years in research, lending to knowledge in dosing, observation, AE documenting, reporting, and subject diary training. Dr. Saraiya has participated in multiple research trials including Obesity, Type 2 Diabetes, Vaccine, and Pain Management among others.

Dr. Peter Lewitt M.D
Dr. Peter LeWitt is a Board-Certified Neurologist with over 20 years of research experience. He has participated in over 100 clinical research trials and over 250 publications within neurology. He is a Movement Disorder Specialist and is joined by an experienced group of staff members who average 18 years of clinical trial expertise. Their independent clinical research site is in an accessible area within a diverse population. His site has a Phase 1 unit equipped for extended overnight trial participation requirements. Among Dr. Lewitt’s trial indication experience is Parkinson’s, Alzheimer’s, movement disorders/motor fluctuations, LIDS, and others.